Chemoinformaics analysis of Pumilaisoflavone B
| Molecular Weight | 464.514 | nRot | 7 |
| Heavy Atom Molecular Weight | 436.29 | nRig | 24 |
| Exact Molecular Weight | 464.184 | nRing | 4 |
| Solubility: LogS | -3.764 | nHRing | 2 |
| Solubility: LogP | 5.59 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 62 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 69.3742 |
| nHD | 1 | BPOL | 37.6378 |
| QED | 0.468 |
| Synth | 3.735 |
| Natural Product Likeliness | 1.766 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.997 |
| Pgp-sub | 0.001 |
| HIA | 0.038 |
| CACO-2 | -4.629 |
| MDCK | 0.0000179 |
| BBB | 0.004 |
| PPB | 0.932327 |
| VDSS | 0.61 |
| FU | 0.0478862 |
| CYP1A2-inh | 0.154 |
| CYP1A2-sub | 0.956 |
| CYP2c19-inh | 0.631 |
| CYP2c19-sub | 0.207 |
| CYP2c9-inh | 0.87 |
| CYP2c9-sub | 0.882 |
| CYP2d6-inh | 0.092 |
| CYP2d6-sub | 0.902 |
| CYP3a4-inh | 0.495 |
| CYP3a4-sub | 0.646 |
| CL | 2.749 |
| T12 | 0.13 |
| hERG | 0.024 |
| Ames | 0.019 |
| ROA | 0.87 |
| SkinSen | 0.244 |
| Carcinogencity | 0.157 |
| EI | 0.038 |
| Respiratory | 0.854 |
| NR-Aromatase | 0.851 |
| Antiviral | Yes |
| Prediction | 0.795115 |